Please provide your email address to receive an email when new articles are posted on . Most women with PCOS treated with tirzepatide experienced 5% or more, 10% or more and 15% or more weight loss.

Weight gain and obesity can disrupt hormonal balance in women, affecting fertility, mood, and overall health. Experts explain the connection and share insights on how to manage weight and restore ...

ATLANTA — Tirzepatide appeared highly effective in reducing weight among women with polycystic ovary syndrome (PCOS) and overweight or obesity, real-world data from a retrospective analysis of over ...

Polycystic ovary syndrome (PCOS) is a hormonal disorder commonly diagnosed in women of childbearing age. While PCOS isn’t an outwardly apparent condition, it can wreak havoc on physical and emotional ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...

Several women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after using GLP-1s such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound. Patients ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of reproductive ...

For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn't until ...